research papers
Structural insight into nucleotide recognition by human death-associated protein kinase
aCenter for Drug Discovery and Chemical Biology, Northwestern University, Chicago, Illinois 60611, USA, bDepartment of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, USA, and cLife Sciences Collaborative Access Team, Advanced Photon Source, Argonne, Illinois 60439, USA
*Correspondence e-mail: j-brunzelle@northwestern.edu
Death-associated protein kinase (DAPK) is a member of the Ca2+/calmodulin-regulated family of serine/threonine protein kinases. The role of the kinase activity of DAPK in eukaryotic cell apoptosis and the ability of bioavailable DAPK inhibitors to rescue neuronal death after brain injury have made it a drug-discovery target for neurodegenerative disorders. In order to understand the recognition of by DAPK and to gain insight into DAPK catalysis, the of human DAPK was solved in complex with ADP and Mg2+ at 1.85 Å resolution. ADP is a product of the kinase reaction and product release is considered to be the rate-limiting step of protein kinase catalytic cycles. The structure of DAPK–ADP–Mg2+ was compared with a newly determined DAPK–AMP-PNP–Mg2+ structure and the previously determined apo DAPK structure (PDB code 1jks). The comparison shows that nucleotide-induced changes are localized to the glycine-rich loop region of DAPK.
Keywords: death-associated protein kinase; serine/threonine protein kinases; nucleotides; glycine-rich loops; Ca2+/calmodulin-regulated protein kinases; apoptosis; brain.
1. Introduction
Death-associated protein kinase (DAPK) is a pro-apoptotic Ca2+/calmodulin-regulated serine/threonine protein kinase (Cohen et al., 1997) that is a drug-discovery target for acute central nervous system (CNS) injuries (Schumacher, Velentza & Watterson, 2002; Velentza et al., 2003; Craft et al., 2004; Shamloo et al., 2005). Acute CNS injuries such as stroke and traumatic brain injury are major causes of death, but the larger societal impact is subsequent morbidity, with life-long compromised functioning among most survivors. Related to the latter point, single-nucleotide polymorphisms (SNPs) in the human DAPK gene have recently been shown to correlate with susceptibility to age-onset Alzheimer's disease (Li et al., 2006). The major impact of these disorders on health and morbidity and the lack of any disease-altering therapies have brought about a high level of scientific interest in the structure and function of DAPK.
Insight into the in vivo mechanisms by which DAPK could be involved in CNS pathophysiology (Schumacher, Velentza, Watterson et al., 2002; Velentza et al., 2003; Craft et al., 2004; Shamloo et al., 2005) has been provided by the identification (Schumacher et al., 2004, 2006) of endogenous CNS protein substrates for DAPK. For example, the and inactivation of a downstream calmodulin-regulated protein kinase involved in neuronal survival by DAPK (Schumacher et al., 2004) and the demonstration that DAPK is an S6 kinase that could alter neuronal cell protein biosynthesis (Schumacher et al., 2006) raise the possibility that DAPK is involved in cascades that modulate the neuronal dysfunction or programmed cell death brought about by stress or injury. The participation of DAPK as an early step in an intracellular protein cascade before the cell is committed to death provides one possible explanation of how a single administration of a bioavailable DAPK inhibitor (Velentza et al., 2003) in an early clinically relevant post-injury therapeutic time window can lead to the subsequent observation of improved neurologic outcomes (Velentza et al., 2003; Shamloo et al., 2005). Overall, in vivo studies and biochemical investigations have established the importance of the DAPK in pathophysiology progression and its potential as a therapeutic target.
Insight into the structural basis of the et al., 2001), combined with molecular model building and activity analyses of peptide-substrate preferences (Velentza et al., 2001). Although crystallographic data are static representations of an average structure, the accumulation of structures of various complexes can provide insights related to the catalytic cycle. It has been noted (Nolen et al., 2003) that examples of direct comparisons of protein kinase structures in the ADP-bound and AMP-PNP-bound forms, which reflect nucleotide product and substrate complexes, respectively, are limited. While additional serine/threonine protein kinase structures (Aoki et al., 2004) and various complexes (Yang et al., 2004) have been reported more recently, examples for the calmodulin-regulated protein kinase family are lacking. Therefore, we determined the structure of the DAPK–ADP–Mg2+ complex, based on the rationale that release of ADP is a rate-limiting step in protein kinase-mediated catalytic cycles (Adams, 2001), and compared its structure with that containing the hydrolysis-resistant ATP analog AMP-PNP and Mg2+ as well as with that of the apo form of DAPK.
of DAPK was initially obtained by determination of the high-resolution crystal structures of the constitutively active DAPK in an apo form and in various complexes containing the ATP analog AMP-PNP (TereshkoOur results presented here provide the first DAPK–ADP–Mg2+ structure and the comparisons among different conformations reveal apparent nucleotide-induced changes in the DAPK structure that are localized to the glycine-rich loop region. The glycine-rich loop is a conserved region of protein kinases that has been proposed to be essential for catalysis (Johnson et al., 2001) and is described by the consensus sequence -Gly-X-Gly-X-X-Gly. The first and second glycines occur in 95 and 99% of kinases, respectively, while the third glycine is conserved in 85% of kinases (Hemmer et al., 1997). DAPK is among the 15% of kinases that lack the third glycine. The results obtained in this study allow a comparative analysis across the three conformations of DAPK.
2. Materials and methods
2.1. Enzyme preparation
The constitutively active et al., 2001), except for the anion-exchange step. Briefly, bacterial cultures were grown in Luria broth at 310 K until the OD600 reached 0.6 and recombinant DNA-encoded expression of DAPK protein was induced by the addition of 0.2 mg anhydrotetracycline per litre of culture. Cultures were grown for an additional 3 h at 310 K and cell pellets were then collected by centrifugation at 5100g for 20 min and stored at 253 K. Rapidly thawed cell pellets were subjected to sonication in 100 mM Tris pH 8.0, 0.25 M NaCl, 0.01% Triton X-100, 0.7 mg l−1 pepstatin A and 1 mM DTT and then centrifuged at 39 000g for 40 min. The supernatant was collected, loaded onto 5 ml Streptactin affinity resin (Qiagen, Valencia, California, USA) and washed with 100 mM Tris–HCl pH 8.0, 0.25 M NaCl; DAPK was eluted with a buffer containing 2.5 mM desthiobiotin, 100 mM Tris–HCl pH 8.0, 0.25 M NaCl. The sample was concentrated at 277 K using 10 000 molecular-weight cutoff concentrators (Vivascience/Sartorius, Aubagne, France) at 5000g for 30 min and the buffer was exchanged for a buffer consisting of 0.25 M NaCl and 100 mM Tris pH 8.0. Purification of human DAPK for structures in the absence of Mg2+ was performed as described previously (Velentza et al., 2001). The protein concentration was determined by UV absorbance at 280 nm using a NanoDrop system (Wilmington, Delaware, USA) and a molar extinction coefficient of 92.7 g−1 ml cm−1. The protein was homogenous by SDS–PAGE and gave the expected molecular chain weight.
of human DAPK, consisting of amino acids 1–285 of the cDNA open reading frame, was expressed and purified as described previously (Velentza2.2. Crystallization and data collection
For the complex of DAPK with ADP (Sigma catalog No. A5410; lot 50H7080) and Mg2+, a protein solution at 5.5 mg ml−1 in 100 mM Tris pH 8.0 and 0.25 M NaCl was incubated with 1 mM ADP and 10 mM MgCl2 for 45 min at 277 K. Crystallization conditions were determined with 96-well plate NeXtal AmSO4 suite screens (catalog No. 130905; Qiagen, Valencia, California, USA) using the sitting-drop method for crystallization. Crystals grew in 0.2 M ammonium chloride, 2.2 M ammonium sulfate pH 5.27 at 295 K and were harvested, soaked in a cryoprotection solution consisting of 0.2 M ammonium chloride, 2.2 M ammonium sulfate, 38% sucrose, 50 mM MgCl2 and 2.8 mM ADP and flash-frozen in liquid nitrogen. Diffraction data were collected using an MX-300 detector (Rayonix LLC, Evanston, Illinois, USA) at 100 K on beamline 21-ID-G (LS-CAT) at the Advanced Photon Source (APS).
For the complex of DAPK with AMP-PNP (Sigma catalog No. A2647; lot 048 K5051) and Mg2+, a protein solution at 5.5 mg ml−1 in 100 mM Tris pH 8.0, 0.25 M NaCl was incubated with 1 mM AMP-PNP and 10 mM MgCl2 for 45 min at 277 K. Crystallization conditions for DAPK–AMP-PNP–Mg2+ were determined analogously to the DAPK–ADP–Mg2+ conditions using AmSO4 suite screens. Crystals grew in 0.2 M NaCl, 2.2 M ammonium sulfate pH 5.25 at 295 K and were harvested, soaked in a cryoprotection solution consisting of 0.2 M NaCl, 2.2 M ammonium sulfate, 30% sucrose, 6.0 mM AMP-PNP and 50 mM MgCl2 and flash-frozen in liquid nitrogen. Diffraction data were collected using an MX-300 detector (Rayonix LLC, Evanston, Illinois, USA) at 100 K on beamline 21-ID-G (LS-CAT) at the APS.
2.3. and refinement
The data sets were integrated and merged using HKL-2000 (Otwinowski & Minor, 1997). Both nucleotide complexes belonged to the orthorhombic P212121, with unit-cell parameters a = 46.8, b = 62.6, c = 88.4 Å for DAPK–ADP–Mg2+ and a = 46.7, b = 62.5, c = 88.6 Å for DAPK–AMP-PNP–Mg2+. Both structures were determined by molecular replacement using MOLREP (Vagin & Teplyakov, 1997); apo DAPK with waters removed at 1.5 Å resolution (PDB code 1jks) was used as the search model. Interactive rounds of model building were performed in Coot (Emsley & Cowtan, 2004), was performed with REFMAC5 (Murshudov et al., 1997) and solvent was added using ARP/wARP (Perrakis et al., 1997). The DAPK–ADP–Mg2+ structure (PDB code 3f5g) had a final crystallographic R factor and Rfree factor of 0.19 and 0.24, respectively. The r.m.s. deviations from the ideal values were 0.015 Å for bond lengths and 1.57° for bond angles. The DAPK–AMP-PNP–Mg2+ structure (PDB code 3f5u) had a final crystallographic R factor and Rfree factor of 0.18 and 0.25, respectively. The r.m.s. deviations from the ideal values were 0.018 Å for bond lengths and 1.77° for bond angles. Data-collection and are shown in Table 1. The structures of the nucleotide complexes in the absence of Mg2+ were determined for the purpose of determining the structural contribution of Mg2+ to the conformational differences observed on superposition. The DAPK–ADP complex (PDB code 3eh9) diffracted to 1.70 Å resolution and the DAPK–AMP-PNP complex (PDB code 3eha) diffracted to 1.60 Å resolution; both were isomorphous to the other DAPK structures. Superpositions of protein structures were calculated over all atoms using least-squares fitting within Coot (Emsley & Cowtan, 2004). Figures were prepared using PyMOL (DeLano, 2002).
‡Rwork = . §5% of the reflections were reserved for calculation of Rfree. |
3. Results and discussion
3.1. Structure of DAPK–ADP–Mg2+ (PDB code 3f5g)
The structure of DAPK complexed with ADP is important because the release of ADP is a rate-limiting step in the kinase-mediated catalytic cycle (Adams, 2001). Our goal was to determine how the recognition of ADP by DAPK induces changes in the positioning of residues relative to other DAPK structures. We used cocrystallization of DAPK with ADP and Mg2+ followed by soaking of DAPK crystals with ADP and Mg2+ in a cryoprotection solvent. Crystallizations were performed under ammonium sulfate conditions similar to those described previously (Tereshko et al., 2001; Velentza et al., 2003). The crystals diffracted to 1.85 Å resolution and were isomorphous to previously determined DAPK structures.
The structure of DAPK–ADP–Mg2+ (Fig. 1a) shows that the structure has the canonical kinase fold consisting of a mainly N-terminal β-sheet and a larger α-helical C-terminal domain. The Fo − Fc OMIT map shows density corresponding to the ADP molecule between the N-terminal and C-terminal domains (Fig. 1b). Density for the adenine ring, the ribose ring, phosphates and one magnesium ion is clearly identifiable.
3.2. Superposition of DAPK–ADP–Mg2+ with apo DAPK
A superposition of DAPK–ADP–Mg2+ and apo DAPK (PDB code 1jks; Tereshko et al., 2001) was calculated by least-squares fitting (Emsley & Cowtan, 2004) over all atoms and an r.m.s. deviation of 0.69 Å was obtained. Overall, the structures of DAPK–ADP–Mg2+ and apo DAPK are mostly superimposable, except for localized differences in the hinge and glycine-rich loop regions. The hinge region has a slight change in positioning that starts at the Cα atom of Val96 and continues through residue Ala97. In the superposition, the Cα atom of Ala97 in the DAPK–ADP–Mg2+ complex (PDB code 3f5g) differs by 0.85 Å from the position of this atom in the apo DAPK structure (Fig. 2). The deviation in the glycine-rich loop of the DAPK structures begins at the Cα atom of Glu17 and continues through Phe24. The structure around Ser21 and Gly22 in DAPK–ADP–Mg2+ is apparently shifted towards the C-terminal domain, resulting in a slight closing of the loop compared with the apo DAPK structure (Fig. 2). The amide N atom of Ser21 in the DAPK–ADP–Mg2+ structure differs by 1.10 Å from its position in the apo DAPK structure. The highly conserved Gly22 can be modeled in two conformations; the amide N of conformation A shown in Fig. 2 differs by 0.93 Å from the apo DAPK structure, while the amide N of conformation B (not shown in the figure) differs by 0.74 Å from the amide N of the apo DAPK structure.
3.3. Structure of DAPK–AMP-PNP–Mg2+ (PDB code 3f5u)
The structure of DAPK–ADP–Mg2+ was compared with the structures of DAPK–AMP-PNP–Mg2+ (PDB code 1jkk) and DAPK–AMP-PNP–Mn2+ (PDB code 1ig1) in order to examine conformational differences between the proteins. This was also performed to compare the detailed interactions of the protein with the nucleotide and the metal ion. However, the structures 1jkk and 1ig1 could not be used for comparison with DAPK–ADP–Mg2+ owing to a lack of discernible density for the nucleotide β- and γ-phosphates. Therefore, we determined a new of DAPK–AMP-PNP–Mg2+ using a combination of cocrystallization of DAPK with AMP-PNP and MgCl2 followed by soaking of crystals in a cryoprotection solution that contained AMP-PNP and MgCl2, similar to the method used to obtain the DAPK–ADP–Mg2+ complex. The DAPK–AMP-PNP–Mg2+ crystals grew in a high concentration of ammonium sulfate and diffracted to 2.00 Å resolution. The crystals were isomorphous to previously determined DAPK structures. The data-collection and are shown in Table 1.
The structure of DAPK–AMP-PNP–Mg2+ (Fig. 3; PDB code 3f5u) was determined and the Fo − Fc OMIT map contained clear density for the nucleotide, including the β- and γ-phosphates and one magnesium ion. The positioning of the γ-phosphate in the new DAPK–AMP-PNP–Mg2+ structure is such that it is in a `kinked' conformation similar to that observed in other kinase–AMP-PNP structures such as PKA (Kim et al., 2005), JNK3 (Xie et al., 1998), GSK3β (Aoki et al., 2004), CDK2 (Brown et al., 1999) and phosphorylase kinase (Lowe et al., 1997). Initial modeling and revealed partial negative density located around the γ-phosphate of the nucleotide, despite the use of the highest purity nucleotide available (see §2). However, this finding is not uncommon in kinase structures. For example, observation of negative density or a lack of density corresponding to the γ-phosphate of AMP-PNP in a kinase complex can be seen in the electron-density maps of structures such as GSK3β–AMP-PNP (PDB code 1pyx), Polo-like kinase 1 (PDB code 2ou7), CK2–AMP-PNP (1lp4), Pim 1 kinase–AMP-PNP (PDB code 1yxt) and serum/glucocorticoid regulated kinase–AMP-PNP (PDB code 2r5t). Nevertheless, our new DAPK–AMP-PNP–Mg2+ data provided an improvement in density that allowed modeling of the γ-phosphate. The adjustment of the occupancies of the γ-phosphate and the OG1, O2G and O3G atoms to 0.60 resulted in elimination of the negative density in the model, thereby allowing a comparative analysis between nucleotide-bound states.
3.4. Comparison of nucleotide and magnesium interactions in DAPK–ADP–Mg2+ and DAPK–AMP-PNP–Mg2+
The determination of a DAPK–ADP–Mg2+ structure and a DAPK–AMP-PNP–Mg2+ structure with sufficient density to allow placement of the β- and γ-phosphates facilitated a comparison of the two protein conformations and examination of the bound in the two DAPK structures. Superposition of DAPK–AMP-PNP–Mg2+ and DAPK–ADP–Mg2+ by a least-squares fit over all atoms revealed an r.m.s. deviation of 0.67 Å between the two structures. Examination of the details of nucleotide interactions in the DAPK–ADP–Mg2+ and DAPK–AMP-PNP–Mg2+ structures revealed conservation of some key distances between the protein and the adenine and ribose portions of the (Figs. 4a and 4b). For example, the adenine bases of AMP-PNP and ADP make conserved contacts with the hinge region of the kinase. The N1 atoms of the adenine rings are both 3.1 Å from the amide N atom of Val96. The N6 atom of the adenine ring is 2.7 Å away from the carboxyl of Glu94. The ribose-ring O2* and O3* atoms make conserved interactions with Glu100 in the ADP and AMP-PNP structures.
An examination of the protein–phosphate interactions revealed several contacts that are conserved among the ADP and AMP-PNP phosphates. The O2A atom of the α-phosphate in the ADP and AMP-PNP structures interacts with a water molecule and the NZ atom of the catalytic Lys42. The β-phosphates of both structures are within proximity of the Cα atom of Gly22 of the glycine-rich loop. Several differences can be noted in the interactions of the β-phosphates. In the ADP structure the β-phosphate O3B atom is within proximity of the Mg2+ ion, while no β-phosphate atoms make contact with the Mg2+ ion of AMP-PNP. The improved density of the γ-phosphate of AMP-PNP allows a closer examination of protein atoms that are within hydrogen-bonding distance of the γ-phosphate atoms and also those atoms within proximity that might be involved in the phospho-transfer process. The only protein atom that is within potential hydrogen-bonding distance is Asp139 OD1 (2.8 Å). Residues which are just beyond hydrogen-bonding distance to the γ-phosphate atoms but may aid in facilitating phospho-transfer include Asp139 (OD1 atom, 3.2 Å), Glu143 (OE2 atom, 4.0 Å), Gly22 (N atom, 4.4 Å), Gln23 (N atom, 3.7 Å) and Asn144 (ND2 atom, 4.4 Å).
In both the AMP-PNP-bound and ADP-bound forms, one magnesium ion is found in each structure. However, it cannot be ruled out that DAPK can bind two Mg2+ ions based on the current crystal structures. This is because the ammonium sulfate crystallization conditions may have competed with a weakly bound second Mg2+ ion. Most kinases will bind two magnesium ions (Adams, 2001). The first site (Mg1) involves the of the β- and γ-phosphates with a conserved Asp. The second site (Mg2) is involved in of the α- and γ-phosphates and is near a conserved Asp and a conserved Asn. The exact roles of the magnesium ions in catalysis can differ between kinases. In PKA, the first site is activating and the second site is inhibitory (Adams, 2001). It has been noted (Nolen et al., 2003) that CDK2, casein kinase 1 and CK2α are examples of active protein kinases with bound ATP or ADP which bind only one Mg2+ ion in the Mg2 site. DAPK is similar to other kinases in that it binds one Mg2+ ion in the Mg2 site in the AMP-PNP-bound and ADP-bound forms, which may be the higher affinity coordination site.
In a superposition of the ADP and AMP-PNP structures, the location of the magnesium ion differs by 1.2 Å (Fig. 5a). The Mg2+ ion in the ADP structure is coordinated to six O atoms, which include the O1A atom of the α-phosphate, the O3B atom of the β-phosphate, a water molecule, Glu143 OE2, Asn144 OD1 and Asp161 OD1. In the AMP-PNP structure, the Mg2+ ion makes fewer interactions with the protein residues and only coordinates to Asp161 OD2, while other interactions are made with the O1A atom of the α-phosphate, the O3G and O2G atoms of the γ-phosphate and a water molecule. An inspection of the of an ADP complex obtained in the absence of Mg2+, DAPK–ADP (PDB code 3eh9), reveals an alternative conformation of the β-phosphate. In this alternative conformation, the phosphate is in a similar location to the position where Mg2+ binds. This raises the possibility that the role of Mg2+ is to assist in the selection of a catalytically preferred conformation of the β-phosphate. In the AMP-PNP structure obtained in the absence of Mg2+, DAPK–AMP-PNP (PDB code 3eha), only subtle changes in interaction distances are seen between the diaxial O atoms of the β- and γ-phosphates and the glycine-rich loop. For example, in the absence of Mg2+, the amide N interaction distances to the diaxial O atom of the β-phosphate are 3.3 Å to Ala25 and 2.9 Å to Asn24. In the Mg2+ structure, these distances are increased to 3.8 and 4.4 Å, respectively.
3.5. Comparison of the glycine-rich loop conformations of DAPK structures
A comparison of the apo DAPK, DAPK–ADP–Mg2+ and DAPK–AMP-PNP–Mg2+ structures revealed an interesting structural change in the glycine-rich loop region. Similar to the comparisons of DAPK–ADP–Mg2+ with the apo and AMP-PNP- and Mg2+-bound forms, a superposition of the DAPK–AMP-PNP–Mg2+ structure and the apo DAPK structure (PDB code 1jks) was calculated so that a comparison of r.m.s deviation values could be generated among all three structures. The r.m.s. deviation was 0.59 Å, which is comparable to the other superpositions. Although all three structures generally superimposed, differences were noted in the topology of the glycine-rich loop encompassing amino acids 20–25 (Fig. 5a). Comparatively, the DAPK–AMP-PNP–Mg2+ structure is a more closed structure, the apo DAPK (PDB code 1jks) structure is a more open structure and the DAPK–ADP–Mg2+ structure is intermediate between the two.
The variance of the glycine-rich loop conformations relative to the apo DAPK structure is reflected in the r.m.s. deviation values calculated over the Cα atoms for residues 20–25. The r.m.s. deviation for these residues between apo DAPK and DAPK–AMP-PNP–Mg2+ is 1.03 Å and that between apo DAPK and DAPK–ADP–Mg2+ is 0.62 Å. A closed conformation of the DAPK–AMP-PNP–Mg2+ and DAPK–ADP–Mg2+ structures indicates that the loop is more ordered, or conformationally restricted, by the phosphate interactions. Stabilization of the glycine-rich loop by an ATP analog is consistent with studies of other protein kinases (Xie et al., 1998; Johnson et al., 2001). An active-site opening and closing that involves changes in the glycine-rich loop conformation would be consistent with the prevailing model of conformational flexibility being essential for catalysis (Johnson et al., 2001). However, the observation that AMP-PNP takes the most closed conformation has not always been observed, as in the case of complexes of the serine-specific kinase Sky1p (Nolen et al., 2003). The trend of a comparatively open and flexible conformation for DAPK–ADP–Mg2+ compared with DAPK–AMP-PNP–Mg2+ might be related to the release of the reaction products ADP and the phosphorylated peptide.
Several assumptions have been made in modeling side chains in this region that deserve mention. Firstly, Gln23 in the glycine-rich loop region is modeled in two different conformations in the DAPK–ADP–Mg2+ structure and in two different conformations in the DAPK–AMP-PNP–Mg2+ structure (Figs. 5b and 5c). Interestingly, a possible stabilizing role of the Gln23 side chain in the ADP structure is suggested by the 2.8 Å distance between Gln23 NE2 and the O3B atom of the β-phosphate (Fig. 4a). The position of Gln23 NE2 occupies the same location as the position of the γ-phosphate in the AMP-PNP structure. In the AMP-PNP structure, the NE2 atom is modeled in a position that is within proximity of the γ-phosphate; however, at 1.0σ density can only be seen for the CA and CB atoms for this conformation, so it is unclear whether Gln23 NE2 is involved in an interaction with the γ-phosphate O atoms (Fig. 5c). The results raise the possibility that Gln23 might be important in the catalytic cycle owing to its potential hydrogen-bonding capability with the β-phosphate of ADP and possibly the γ-phosphate of AMP-PNP, thereby contributing to the conformational adaptability that is key to catalysis.
Secondly, Phe24 also appears to have conformational variability. The conformation of the side chain of Phe24 in apo DAPK and DAPK–ADP–Mg2+ is up towards the N-terminal domain. In the AMP-PNP-bound form, an alternative conformation of Phe24 with the side chain down towards the C-terminal domain can be modeled in a conformation distinct from the conformation in DAPK–ADP and apo DAPK (Fig. 5c). The two conformations result in a 1.6 Å difference in the Cα atom of Phe24.
The three DAPK conformations demonstrate that nucleotide binding brings about changes in conformation that are mostly localized to the glycine-rich loop region. This trend is consistent with the results for other protein kinases (Yang et al., 2004; Xie et al., 1998; Nolen et al., 2003; Eswaran et al., 2007; Lowe et al., 1997). Interestingly, Gln23 within the glycine-rich loop may play a role in regulating ADP binding/release, which is the rate-limiting step in the catalytic mechanism. The mutagenesis of this residue and an examination of the effects on would be an interesting test of the hypothesis in future studies.
4. Conclusions
The determination of the first DAPK–ADP–Mg2+ structure and the determination of a new DAPK–AMP-PNP–Mg2+ structure allowed a comparative analysis of three different DAPK conformations relevant to the catalytic cycle: a form containing no bound nucleotide, a form containing a nonhydrolyzable analog of the ATP substrate and a form containing the reaction product ADP. The comparisons revealed discrete localized conformational changes in DAPK as a result of changes in nucleotide binding. The most notable conformational changes occur in the glycine-rich loop region, an active-site region with potential for modulation of kinase activity.
Acknowledgements
We thank Drs Ludmilla Shuvalova, George Minasov and Wayne Anderson for their assistance and advice. This research was supported by National Institutes of Health awards NS047586 and NS056051 (DMW). Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. W-31-109-Eng-38.
References
Adams, J. A. (2001). Chem. Rev. 101, 2271–2290. Web of Science CrossRef PubMed CAS Google Scholar
Aoki, M., Yokota, T., Sugiura, I., Sasaki, C., Hasegawa, T., Okumura, C., Ishiguro, K., Kohno, T., Sugio, S. & Matsuzaki, T. (2004). Acta Cryst. D60, 439–446. Web of Science CrossRef CAS IUCr Journals Google Scholar
Brown, N. R., Noble, M. E. M., Endicott, J. A. & Johnson, L. N. (1999). Nature Cell. Biol. 1, 438–443. Web of Science PubMed CAS Google Scholar
Cohen, O., Feinstein, E. & Kimchi, A. (1997). EMBO J. 15, 998–1008. CrossRef Web of Science Google Scholar
Craft, J. M., Watterson, D. M., Frautschy, S. A. & Van Eldik, L. J. (2004). Neurobiol. Aging, 25, 1283–1292. Web of Science CrossRef PubMed CAS Google Scholar
DeLano, W. L. (2002). The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, California, USA. Google Scholar
Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132. Web of Science CrossRef CAS IUCr Journals Google Scholar
Eswaran, J., Lee, W. H., Debreczeni, J. É., Filippakopoulos, P., Turnbull, A., Federov, O., Deacon, S. W., Peterson, J. R. & Knapp, S. (2007). Structure, 15, 201–213. Web of Science CrossRef PubMed CAS Google Scholar
Hemmer, W., McGlones, M., Tsigelny, I. & Taylor, S. S. (1997). J. Biol. Chem. 272, 16946–16954. CrossRef CAS PubMed Web of Science Google Scholar
Johnson, D. A., Akamine, P., Radzio-Andzelm, E., Madhusudan & Taylor, S. S. (2001). Chem. Rev. 101, 2243–2270. Google Scholar
Kim, C., Xuong, N.-H. & Taylor, S. S. (2005). Science, 307, 690–696. Web of Science CrossRef PubMed CAS Google Scholar
Li, Y. et al. (2006). Hum. Mol. Genet. 15, 2560–2568. Web of Science CrossRef PubMed CAS Google Scholar
Lowe, E. D., Noble, M. E. M., Skamnaki, V. T., Oikonomakos, N. G., Owen, D. J. & Johnson, L. N. (1997). EMBO J. 16, 6646–6658. CrossRef CAS PubMed Web of Science Google Scholar
Murshudov, G. N., Vagin, A. A. & Dodson, E. J. (1997). Acta Cryst. D53, 240–255. CrossRef CAS Web of Science IUCr Journals Google Scholar
Nolen, B., Ngo, J., Chakrabarti, S., Vu, D., Adams, J. A. & Ghosh, G. (2003). Biochemistry, 42, 9575–9585. Web of Science CrossRef PubMed CAS Google Scholar
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. CrossRef CAS PubMed Web of Science Google Scholar
Perrakis, A., Sixma, T. K., Wilson, K. S. & Lamzin, V. S. (1997). Acta Cryst. D53, 448–455. CrossRef CAS Web of Science IUCr Journals Google Scholar
Schumacher, A. M., Schavocky, J. P., Velentza, A. V., Mirzoeva, S. & Watterson, D. M. (2004). Biochemistry, 43, 8116–8124. Web of Science CrossRef PubMed CAS Google Scholar
Schumacher, A. M., Velentza, A. V. & Watterson, D. M. (2002). Expert Opin. Ther. Targets, 6, 497–506. CrossRef PubMed CAS Google Scholar
Schumacher, A. M., Velentza, A. V., Watterson, D. M. & Dresios, J. (2006). Biochemistry, 45, 13614–13621. Web of Science CrossRef PubMed CAS Google Scholar
Schumacher, A. M., Velentza, A. V., Watterson, D. M. & Wainwright, M. S. (2002). Biochim. Biophys. Acta, 1600, 128–137. Web of Science CrossRef PubMed CAS Google Scholar
Shamloo, M., Soriano, L., Wieloch, T., Nikolich, K., Urfer, R. & Oksenberg, D. (2005). J. Biol. Chem. 280, 42290–42299. Web of Science CrossRef PubMed CAS Google Scholar
Tereshko, V., Teplova, M., Brunzelle, J., Watterson, D. M. & Egli, M. (2001). Nature Struct. Biol. 8, 899–907. Web of Science CrossRef PubMed CAS Google Scholar
Vagin, A. & Teplyakov, A. (1997). J. Appl. Cryst. 30, 1022–1025. Web of Science CrossRef CAS IUCr Journals Google Scholar
Velentza, A. V., Schumacher, A. M., Weiss, C., Egli, M. & Watterson, D. M. (2001). J. Biol. Chem. 276, 38956–38965. Web of Science CrossRef PubMed CAS Google Scholar
Velentza, A. V., Wainwright, M. S., Zasadzki, M., Mirzoeva, S., Schumacher, A. M., Haiech, J., Focia, P. J., Egli, M. & Watterson, D. M. (2003). Bioorg. Med. Chem. Lett. 13, 3465–3470. Web of Science CrossRef PubMed CAS Google Scholar
Xie, X., Gu, Y., Fox, T., Coll, J. T., Fleming, M. A., Markland, W., Caron, P. R., Wilson, K. P. & Su, M. S.-S. (1998). Structure, 6, 983–991. Web of Science CrossRef CAS PubMed Google Scholar
Yang, J., Ten Eyck, L. F., Xuong, N.-H. & Taylor, S. S. (2004). J. Mol. Biol. 336, 473–487. Web of Science CrossRef PubMed CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.